Back to results
US 2013/0280195 A1Published application
Compositions for use in treatment of dermatological diseases and conditions and methods of use thereof
AssigneeDermaMedics, LLC
InventorBryan B. Fuller
Life of this patent
Estimating the term…
Abstract
Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed. Methods of using the compositions are also disclosed.
Claims25
A transdermal composition, comprising:
- an effective dermatological disease-treating or dermatological condition-treating amount of an active agent comprising soluble ethyl vanillin and/or a salt thereof;
- and
- a pharmaceutically-acceptable carrier or vehicle effective in carrying or enabling passage of the active agent into the epidermis or dermis of the skin of the subject where the active agent has its effect on the dermatological disease or dermatological condition, and wherein the pharmaceutically-acceptable carrier or vehicle is non-aqueous and is absent emulsifiers and wherein the soluble ethyl vanillin retains its stability in the composition for at least 3 months.
A method of treating a dermatological condition in a subject's skin, the method comprising:
- topically administering an effective amount of a transdermal composition to a portion of the subject's skin which is affected by a dermatological condition which is at least one of scarring and aging, wherein the transdermal composition comprises:
- an active agent comprising at least one of soluble ethyl vanillin and a salt thereof;
- and
- a pharmaceutically-acceptable carrier or vehicle effective in carrying or enabling passage of the active agent into the epidermis or dermis of the skin of the subject where the active agent has its effect on the at least one of scarring and aging, and wherein the pharmaceutically-acceptable carrier or vehicle is non-aqueous and is absent emulsifiers and wherein the at least one of the soluble ethyl vanillin and the salt thereof retains its stability in the composition for at least 3 months.
1 more element
Dependencies are inferred from the claim text.